NAT10 and bladder transitional cell carcinoma: Kaplan–Meier curves with a log‐rank test showed that patients with low NAT10 expression had better overall survival, suggesting a possible role of NAT10 in predicting prognosis and promoting the progression of BLCA (Figure 1D).